Form 4 for IMNM Immunome Inc.
Accepted 2026-06-17 17:26:19 ET · period of report 2026-06-15 · accession 0001994071-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-17 17:26 | 2026-06-15 | IMNM | Rosett Max | CFO | M - OptEx | $1.05 | +60.0K | 114.0K | +111% | +$63.0K |
| DT | 2026-06-17 17:26 | 2026-06-15 | IMNM | Rosett Max | CFO | S - Sale+OE | $18.23 | -60.0K | 54.0K | -53% | -$1.09M |
| DT | 2026-06-17 17:26 | 2026-06-15 | IMNM | Rosett Max | CFO | M - OptEx | $0.00 | -60.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-15 | M | A | 60,000 | $1.05 | 114,037 | D | — | — | |
| 2 | Common | Common Stock | 2026-06-15 | S | D | 60,000 | $18.23 | 54,037 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025. (F2) The weighted average purchase price for the transaction report was $18.23, and the range of prices were between $17.95 and $18.66, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided. |
| 3 | Derivative | Stock Option (right to buy) | 2026-06-15 | M | D | 60,000 | $0.00 | 0 | D | $1.05 · — to 2033-03-22 | 60,000 Common Stock | (F3) The option is fully vested. |